Prognoscan is a useful online tool for assessing the association between specific gene expression and prognosis of cancer patients and based on a large collection of cancer microarray datasets with clinical annotation. We used the Prognoscan platform to validate the prognostic value of RCC1 expression in patients with lung adenocarcinoma or squamous cell carcinoma.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.